Cardiovascular Analytics Group
@cvanalytics2015
Followers
157
Following
50
Statuses
115
The Cardiovascular Analytics Group was established in 2015, with the aim of providing an open platform for collaborative research across different institutions
Joined July 2021
Thanks to the hard work of our team members, we have 14 papers in quartile 1 journals of which 12 are in the top 15%. @HealthcareAI_UK
0
4
7
Beautiful. You can search predatory publishers and journals! Group members, collaborators and friends. @FrontiersIn @MDPIOpenAccess
To celebrate a new year full of work, we added a search bar on our website to make it easier to find predatory journals and publishers in The List. Just go to:
0
1
1
Our book on Internet of Things in diabetes mellitus is now available for pre-order at Elsevier or Amazon: Editors: Sujata Dash, Subhendu Kumar Pani, Willy Susilo, Cheung Man Yung Bernard, Gary Tse @cvanalytics2015
@GaryTse1
@HealthcareAI_UK
0
3
4
Calling for book chapters on the use of big data/new diagnostic technology for cardiovascular diseases Edited by @DrHaipengLiu from Coventry and I. @HealthcareAI_UK
@CRCPress
0
3
4
RT @adribaran: Here with Dr. Sharen Lee from Hong Kong visiting us in Kingston! Go @cvanalytics2015 for more research together in 2024!!…
0
2
0
Our team found that any OCS use was associated with higher risk of adverse outcomes in patients with COPD, with risk generally increasing with greater cumulative OCS dose. More here at the Int J of COPD: @GaryTse1 @HealthcareAI_UK
0
1
1
Initiating warfarin shortly after IE diagnosis was associated with reduced 90-day mortality risk by 50% compared to non-use. @GaryTse1 @sharen212 @JeffreyChansky @HealthcareAI_UK Published in @ThrombosisRese1
0
2
4
Hot in the press. SGLT2i use is associated with lower risks of syncope vs. DPP4i. Published in EHJ CV Pharmacotherapy. @GaryTse1 @JdongZhou @HealthcareAI_UK
0
2
11
Our team member Dr Helen Huang talks about the use of liver indices to predict AF and stroke in diabetes. Presented at the Liver Meeting in Boston. @AASLDtweets
@AASLDFoundation
@cvanalytics2015
@HealthcareAI_UK
@GaryTse1 @jia
0
2
13
We wrote an editorial back in 2018 on the lack of availability of CVD risk models for non-Western populations. 5 years later we developed our complex AI-driven model. Our team now propose a beside model , incorporating effects of long COVID, Covid vaccines & treatments.@GaryTse1
0
0
3
RT @Satti_DI: 1/ Our latest📝in @JACCJournals #JACCCardioOnc explores the relationships between #SDOH and #CVH of cancer survivors in the US…
0
7
0
Congratulations to @gbiondizoccai
@GaryTse1
@HarkyAmer
@adribaran
@LeonardoRoever
@Nicholaswschew for making the Stanford Top 2% Scientists (2023) for the Cardiovascular System subfield for single year citations and/or career long citations.
1
4
7
Congratulations to @gbiondizoccai @GaryTse1 @HarkyAmer @adribaran @LeonardoRoever for making the Stanford Top 2% Scientists (2023) for the Cardiovascular System subfield for single year citations and/or career long citations.
0
4
11
Our team developed PowerAI-CVD, the first Chinese-specific, validated AI- powered CVD risk model. @GaryTse1 @HealthcareAI_UK @DrHaipengLiu @AbrahamKWai1 More here:
0
0
4
Members of our team presented their oral presentations and moderated posters at the @escardio congress in Amsterdam. @HealthcareAI_UK @GaryTse1
0
4
5
RT @ResrchLib_cccu: New #research: Association between serum uric acid and #ProstateCancer mortality in androgen deprivation therapy: A pop…
0
4
0
RT @adribaran: Here with: - Varna: past president - Ikeda: immediate past president - Vass: new President - Baranchuk: new President elect…
0
5
0